[go: up one dir, main page]

ZA977745B - Transdermal delivery of peptides - Google Patents

Transdermal delivery of peptides

Info

Publication number
ZA977745B
ZA977745B ZA977745A ZA977745A ZA977745B ZA 977745 B ZA977745 B ZA 977745B ZA 977745 A ZA977745 A ZA 977745A ZA 977745 A ZA977745 A ZA 977745A ZA 977745 B ZA977745 B ZA 977745B
Authority
ZA
South Africa
Prior art keywords
peptides
transdermal delivery
transdermal
delivery
Prior art date
Application number
ZA977745A
Inventor
Helle Weibel
Peter Hongaard Andersen
Astrid Spillum
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA977745B publication Critical patent/ZA977745B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA977745A 1996-08-29 1997-08-28 Transdermal delivery of peptides ZA977745B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK90996 1996-08-29

Publications (1)

Publication Number Publication Date
ZA977745B true ZA977745B (en) 1998-08-11

Family

ID=8098895

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA977745A ZA977745B (en) 1996-08-29 1997-08-28 Transdermal delivery of peptides

Country Status (3)

Country Link
AU (1) AU3938797A (en)
WO (1) WO1998008492A1 (en)
ZA (1) ZA977745B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205692A1 (en) * 1997-05-16 1998-11-16 Hyal Pharmaceutical Corporation Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
US6039977A (en) * 1997-12-09 2000-03-21 Alza Corporation Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
IL152574A (en) 2002-10-31 2009-09-22 Transpharma Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7662404B2 (en) 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8420605B2 (en) * 2005-09-07 2013-04-16 The University Of Strathclyde Hydrogel compositions
KR20080066712A (en) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 Functionalized Microneedle Transdermal Drug Delivery System, Apparatus and Method
KR20090056985A (en) * 2006-08-29 2009-06-03 알자 코포레이션 Drug Electric Transport Using Hydration Measurement of Hydable Reservoir
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US7402564B1 (en) 2006-11-10 2008-07-22 Cara Therapeutics, Inc. Synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
CA2710039C (en) 2007-12-26 2018-07-03 Critical Outcome Technologies, Inc. Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer
WO2010006438A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
WO2017136557A1 (en) 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153469T3 (en) * 1993-12-23 2001-03-01 Novo Nordisk As COMPOUNDS WITH PROPERTIES TO RELEASE THE GROWTH HORMONE.
CZ287948B6 (en) * 1995-06-22 2001-03-14 Novo Nordisk A/S Peptide derivative releasing growth hormone, pharmaceutical preparation in which it is comprised and use thereof

Also Published As

Publication number Publication date
WO1998008492A1 (en) 1998-03-05
AU3938797A (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ZA977745B (en) Transdermal delivery of peptides
IL120943A0 (en) Transdermal delivery system
AUPO066096A0 (en) Oral delivery of peptides
HUP0000522A3 (en) N-acyl phoshpatidylethanolamine-mediated liposomal drug delivery
EP0941120A4 (en) Branched peptide linkers
IL123258A0 (en) Opioid peptides
HRP970308A2 (en) Peptide derivatives
IL125804A0 (en) Peptide derivatives
PL339085A1 (en) Recombinative expression of insulin peptide c
GB9718110D0 (en) Peptides
GB9700154D0 (en) Peptides
GB9624562D0 (en) Peptide derivatives
GB9714276D0 (en) Peptides and related compounds
EP0935608A4 (en) Cytotoxic peptides
IL127565A0 (en) Virginiamycin mixture
GB9606272D0 (en) Gene and peptides
ZA978027B (en) The use of muramyl peptides
IL113441A0 (en) Opioid peptide analoog
GB9613705D0 (en) Novel peptides
AU2944197A (en) Oral delivery of peptides
SG55039A1 (en) Peptides
GB9612648D0 (en) Peptides
GB9606765D0 (en) Peptides
GB9605904D0 (en) Peptides
GB9626362D0 (en) Peptides